QuantumPharm, Inc. (HK:2228) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
XtalPi Holdings Limited, formerly known as QuantumPharm Inc., announced the granting of 1.8 million restricted stock units (RSUs) to three independent non-executive directors as part of its Post-IPO RSU Scheme. This move aims to incentivize and retain key contributors to the company’s long-term growth, with vesting periods extending through December 2028. The shares were granted at no purchase price, with the closing price on the grant date recorded at HK$5.55.
For further insights into HK:2228 stock, check out TipRanks’ Stock Analysis page.